Literature DB >> 27573510

Antiepileptic drugs, foetal malformations and spontaneous abortions.

F J E Vajda1, T J O'Brien1, J E Graham1, A A Hitchcock1, C M Lander2, M J Eadie2.   

Abstract

BACKGROUND: Some recent studies have found an association between foetal malformations in earlier antiepileptic drug (AED)-exposed pregnancies and an increased hazard of such malformations in subsequent pregnancies. We investigated this matter further, and also considered the possible role of spontaneous abortions in previous pregnancies, in this situation.
METHODS: Analysis of foetal malformation data for current and previous pregnancies in women taking AEDs and women with untreated epilepsy in the Australian Register of Antiepileptic Drugs in Pregnancy (APR) from 1999 to late 2014.
RESULTS: Antiepileptic drug-treated women with either a malformed foetus or a spontaneous abortion in their previous pregnancy had a statistically significant twofold to threefold increased risk of foetal malformation in their next pregnancy, compared with similarly treated women with normal offspring in their previous pregnancy. This was not seen in the same circumstances in women with untreated epilepsy. On AED treatment, the women were more likely to have spontaneous abortions than in their previous untreated pregnancies. Possibly some of the increased abortion rate resulted from drug-related malformations that were incompatible with continuing intrauterine survival.
CONCLUSIONS: In assessing the hazard of an AED-treated woman having a malformed foetus, it is important to know both the AEDs being taken and, if there had been a previous pregnancy, whether a foetal malformation or a spontaneous abortion occurred in it.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  abortion; antiepileptic drug; foetus; malformations; miscarriage

Mesh:

Substances:

Year:  2016        PMID: 27573510     DOI: 10.1111/ane.12672

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Fertility and Birth Outcomes in Women With Epilepsy Seeking Pregnancy.

Authors:  Page B Pennell; Jacqueline A French; Cynthia L Harden; Anne Davis; Emilia Bagiella; Evie Andreopoulos; Connie Lau; Nichelle Llewellyn; Sarah Barnard; Stephanie Allien
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

2.  Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy.

Authors:  Ye Ding; Xiaoping Tan; Shuo Zhang; Yang Guo
Journal:  Brain Behav       Date:  2019-05-18       Impact factor: 2.708

3.  Socio-demographic profiles and obstetrics outcomes of pregnant women with epilepsy in a vulnerability State, Brazil.

Authors:  Magnúcia de Lima Leite; Tatiana Natasha Toporcov; Janise Dal Pai; José Claudio da Silva
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

4.  Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health.

Authors:  Barbara Mostacci; Francesca Bisulli; Elisabetta Poluzzi; Guido Cocchi; Carlo Piccinni; Alessandra Curti; Giuliana Simonazzi; Gianni Astolfi; Nicola Rizzo; Corrado Zenesini; Roberto D'Alessandro; Paolo Tinuper
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-03-16       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.